Dr. Paul Shapiro is a professor in the Department of Pharmaceutical Sciences and associate dean of research and advanced graduate studies at the University of Maryland School of Pharmacy.
Dr. Shapiro received his Bachelor of Science from the University of Wisconsin-Madison in 1987, and his doctorate in molecular physiology and biophysics from the University of Vermont in 1995. He completed post-doctoral training from 1995-1999 in the Department of Chemistry and Biochemistry at the University of Colorado-Boulder.
Dr. Shapiro’s research focuses on protein kinases and their role in regulating signaling pathways that control cellular functions and dysregulation of protein kinases during disease. Specific areas of research focus on the discovery and development of novel small molecules that inhibit the extracellular signal-regulated kinases (ERK1/2) and p38 MAP kinases and provide the rationale for clinical applications of these molecules in treating cancer or inflammatory disease.